These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30256785)

  • 1. Manipulating the revision of reward value during the intertrial interval increases sign tracking and dopamine release.
    Lee B; Gentry RN; Bissonette GB; Herman RJ; Mallon JJ; Bryden DW; Calu DJ; Schoenbaum G; Coutureau E; Marchand AR; Khamassi M; Roesch MR
    PLoS Biol; 2018 Sep; 16(9):e2004015. PubMed ID: 30256785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cocaine Self-Administration Experience Induces Pathological Phasic Accumbens Dopamine Signals and Abnormal Incentive Behaviors in Drug-Abstinent Rats.
    Saddoris MP; Wang X; Sugam JA; Carelli RM
    J Neurosci; 2016 Jan; 36(1):235-50. PubMed ID: 26740664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impacts of inter-trial interval duration on a computational model of sign-tracking vs. goal-tracking behaviour.
    Cinotti F; Marchand AR; Roesch MR; Girard B; Khamassi M
    Psychopharmacology (Berl); 2019 Aug; 236(8):2373-2388. PubMed ID: 31367850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethanol Exposure History and Alcoholic Reward Differentially Alter Dopamine Release in the Nucleus Accumbens to a Reward-Predictive Cue.
    Fiorenza AM; Shnitko TA; Sullivan KM; Vemuru SR; Gomez-A A; Esaki JY; Boettiger CA; Da Cunha C; Robinson DL
    Alcohol Clin Exp Res; 2018 Jun; 42(6):1051-1061. PubMed ID: 29602178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sign Tracking and Goal Tracking Are Characterized by Distinct Patterns of Nucleus Accumbens Activity.
    Gillis ZS; Morrison SE
    eNeuro; 2019; 6(2):. PubMed ID: 30886890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sensory features of a food cue influence its ability to act as an incentive stimulus and evoke dopamine release in the nucleus accumbens core.
    Singer BF; Bryan MA; Popov P; Scarff R; Carter C; Wright E; Aragona BJ; Robinson TE
    Learn Mem; 2016 Nov; 23(11):595-606. PubMed ID: 27918279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine in the dorsal bed nucleus of stria terminalis signals Pavlovian sign-tracking and reward violations.
    Gyawali U; Martin DA; Sun F; Li Y; Calu D
    Elife; 2023 May; 12():. PubMed ID: 37232554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual reward prediction components yield Pavlovian sign- and goal-tracking.
    Kaveri S; Nakahara H
    PLoS One; 2014; 9(10):e108142. PubMed ID: 25310184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of NMDA receptors in dopamine neurons attenuates dopamine release but not conditioned approach during Pavlovian conditioning.
    Parker JG; Zweifel LS; Clark JJ; Evans SB; Phillips PE; Palmiter RD
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13491-6. PubMed ID: 20616081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-lasting contribution of dopamine in the nucleus accumbens core, but not dorsal lateral striatum, to sign-tracking.
    Fraser KM; Janak PH
    Eur J Neurosci; 2017 Aug; 46(4):2047-2055. PubMed ID: 28699296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine antagonism does not impair learning of Pavlovian conditioned approach to manipulable or non-manipulable cues but biases responding towards goal tracking.
    Scülfort SA; Bartsch D; Enkel T
    Behav Brain Res; 2016 Nov; 314():1-5. PubMed ID: 27478141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling individual differences in the form of Pavlovian conditioned approach responses: a dual learning systems approach with factored representations.
    Lesaint F; Sigaud O; Flagel SB; Robinson TE; Khamassi M
    PLoS Comput Biol; 2014 Feb; 10(2):e1003466. PubMed ID: 24550719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extinction and reinstatement of phasic dopamine signals in the nucleus accumbens core during Pavlovian conditioning.
    Sunsay C; Rebec GV
    Behav Neurosci; 2014 Oct; 128(5):579-87. PubMed ID: 25111335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic shaping of dopamine signals during probabilistic Pavlovian conditioning.
    Hart AS; Clark JJ; Phillips PEM
    Neurobiol Learn Mem; 2015 Jan; 117():84-92. PubMed ID: 25172480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of dopamine in the accumbens core in the expression of Pavlovian-conditioned responses.
    Saunders BT; Robinson TE
    Eur J Neurosci; 2012 Aug; 36(4):2521-32. PubMed ID: 22780554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased Ventral Tegmental Area CB1R Signaling Reduces Sign Tracking and Shifts Cue-Outcome Dynamics in Rat Nucleus Accumbens.
    Bacharach SZ; Martin DA; Stapf CA; Sun F; Li Y; Cheer JF; Calu DJ
    J Neurosci; 2023 Jun; 43(25):4684-4696. PubMed ID: 37208179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of inter-trial interval on sign-tracking and conditioned reinforcer efficacy in female rats.
    Mahmoudi S; Peck S; Madden GJ
    Behav Processes; 2023 Aug; 210():104911. PubMed ID: 37406869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual differences in the propensity to approach signals vs goals promote different adaptations in the dopamine system of rats.
    Flagel SB; Watson SJ; Robinson TE; Akil H
    Psychopharmacology (Berl); 2007 Apr; 191(3):599-607. PubMed ID: 16972103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Dopamine Release Dynamics in the Nucleus Accumbens Core and Shell Reveal Complementary Signals for Error Prediction and Incentive Motivation.
    Saddoris MP; Cacciapaglia F; Wightman RM; Carelli RM
    J Neurosci; 2015 Aug; 35(33):11572-82. PubMed ID: 26290234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid receptor-1 signaling contributions to sign-tracking and conditioned reinforcement in rats.
    Bacharach SZ; Nasser HM; Zlebnik NE; Dantrassy HM; Kochli DE; Gyawali U; Cheer JF; Calu DJ
    Psychopharmacology (Berl); 2018 Oct; 235(10):3031-3043. PubMed ID: 30109373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.